These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15731142)

  • 21. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluating drug effects in the post-Vioxx world: there must be a better way.
    Avorn J
    Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cyclooxygenase inhibitors: a never ending story?].
    Macrì R; Manfredi C
    G Ital Cardiol (Rome); 2006 Jul; 7(7):505-7. PubMed ID: 16977790
    [No Abstract]   [Full Text] [Related]  

  • 24. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Shinmura K; Bolli R
    Ann Intern Med; 2005 Oct; 143(8):617; author reply 617-8. PubMed ID: 16230737
    [No Abstract]   [Full Text] [Related]  

  • 25. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Pijak MR; Huzicka I; Gazdik F
    Ann Intern Med; 2005 Oct; 143(8):616-7; author reply 617-8. PubMed ID: 16230736
    [No Abstract]   [Full Text] [Related]  

  • 26. [Overestimated].
    Höer A; Häussler B
    Med Klin (Munich); 2006 Aug; 101(8):676-7; author reply 678-9. PubMed ID: 17051671
    [No Abstract]   [Full Text] [Related]  

  • 27. Does the dose make the poison?
    Harris RE
    Science; 2005 Apr; 308(5719):203. PubMed ID: 15821073
    [No Abstract]   [Full Text] [Related]  

  • 28. [A new pharmacological principle is effective--rofecoxib. Specific COX-2 inhibition].
    MMW Fortschr Med; 1999 Dec; 141(51-52):66-7. PubMed ID: 10949630
    [No Abstract]   [Full Text] [Related]  

  • 29. Vioxx risk could signify trouble in class.
    Frantz S
    Nat Rev Drug Discov; 2004 Nov; 3(11):899-901. PubMed ID: 15558856
    [No Abstract]   [Full Text] [Related]  

  • 30. Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?
    Howes LG; Krum H
    Drug Saf; 2002; 25(12):829-35. PubMed ID: 12241124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDA refuses companies' request to drop ulcer warning.
    Gottlieb S
    BMJ; 2001 Feb; 322(7283):385. PubMed ID: 11179151
    [No Abstract]   [Full Text] [Related]  

  • 32. Arthritis drug raises risk of sudden heart attack.
    Health News; 2004 Oct; 10(10):2. PubMed ID: 15584106
    [No Abstract]   [Full Text] [Related]  

  • 33. Wolf in sheep's clothing?
    Varga J
    Am J Hosp Palliat Care; 2000; 17(4):280. PubMed ID: 11883807
    [No Abstract]   [Full Text] [Related]  

  • 34. Merck withdraws arthritis drug worldwide.
    Singh D
    BMJ; 2004 Oct; 329(7470):816. PubMed ID: 15472245
    [No Abstract]   [Full Text] [Related]  

  • 35. COX-2 selective inhibitors--important lessons learned.
    Maxwell SR; Webb DJ
    Lancet; 2005 Feb 5-11; 365(9458):449-51. PubMed ID: 15705439
    [No Abstract]   [Full Text] [Related]  

  • 36. [Thinking about the specific cyclooxygenase-2 inhibitors since its recommendation].
    Shi G
    Zhonghua Nei Ke Za Zhi; 2001 Sep; 40(9):579-80. PubMed ID: 11758234
    [No Abstract]   [Full Text] [Related]  

  • 37. The perioperative use of cyclooxygenase-2 selective nonsteroidal antiinflammatory drugs may offer a safer alternative.
    Reuben SS; Connelly NR
    Anesthesiology; 2004 Mar; 100(3):748. PubMed ID: 15109000
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute, anuric renal failure associated with two doses of a cyclooxygenase-2 inhibitor.
    Wahba AL; Soper C
    Nephron; 2001 Oct; 89(2):239. PubMed ID: 11549912
    [No Abstract]   [Full Text] [Related]  

  • 39. Acute urinary retention associated with the use of cyclooxygenase-2 inhibitors.
    Gruenenfelder J; McGuire EJ; Faerber GJ
    J Urol; 2002 Sep; 168(3):1106. PubMed ID: 12187239
    [No Abstract]   [Full Text] [Related]  

  • 40. Probable rofecoxib-induced thrombocytopenia.
    Kentos A; Robin V; Lambermont M; Jurdan M; Pignarelli M; Feremans W
    Rheumatology (Oxford); 2003 May; 42(5):699-700. PubMed ID: 12709555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.